Abstract: Heteroaryl-fused macrocyclic 2,4-diaminopyrimidine compounds of formula (I) wherein W, G1, G2, A1 and R1 are defined in the description, compositions comprising such compounds, methods for making the compounds, and methods of treating and preventing the progression of diseases, conditions, and disorders using such compounds and compositions are described herein.
Type:
Grant
Filed:
May 5, 2009
Date of Patent:
October 1, 2013
Assignee:
AbbVie Inc.
Inventors:
Huaqing Liu, Irene Drizin, Marlon D. Cowart, Robert J. Altenbach